{"data":{"type":"feed_item","id":319473,"entity_id":"wefunder:feed_item:319473","attributes":{"canonical_url":"https://wefunder.com/feed/319473","retrieval_urls":{"canonical":"https://wefunder.com/feed/319473","json":"https://wefunder.com/feed/319473.json","markdown":"https://wefunder.com/feed/319473.md","ai_json":"https://wefunder.com/feed/319473.ai.json","ai_text":"https://wefunder.com/feed/319473.ai.txt","changelog_json":"https://wefunder.com/feed/319473.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-05-25T05:17:48.092Z","generated_at":"2026-06-24T08:15:56Z","profile_visibility":"public","feed_item":{"id":319473,"entity_id":"wefunder:feed_item:319473","type":"FeedItem::Update","title":"FDA Grants Our End of Phase 2 Meeting Request | Sen-Jam Pharmaceutical","content_plain":"Dear Sen-Jam Investors \u0026amp; Community, The FDA has granted our End-of-Phase 2 meeting request for SJP-001, scheduled for July 1. Following this meeting, we expect to receive the official FDA meeting minutes in August — a critical regulatory miles...","published_at":"2026-05-11T15:09:16.868Z","updated_at":"2026-05-25T05:17:48.092Z","canonical_url":"https://wefunder.com/feed/319473","author":{"name":"Jim Iversen","profile_url":"https://wefunder.com/jimiversen2"},"subject":{"name":"Sen-Jam Pharmaceutical","profile_url":"https://wefunder.com/senjam"}},"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2026-05-25T05:17:48Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2026-05-25T05:17:48Z","as_of":"2026-05-25T05:17:48Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2026-05-25T05:17:48Z","as_of":"2026-05-11T15:09:16Z","confidence":"high"}}}}}}